We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Lung Eosinophils Play Protective and Beneficial Role

By LabMedica International staff writers
Posted on 08 Sep 2016
During allergic reactions such as asthma, the immune system does not work correctly and responds in an abnormal way to harmless allergens present in the environment such as pollen and dust mites.

In an asthmatic individual, the eosinophil cells which are a type of granulocytes that are produced in the bone marrow and which circulate in the body via the blood and are recruited to the lungs where they participate to the pathological manifestations associated with an asthmatic reaction.

An international team of scientists led by those at the University of Liege (Belgium) identified the existence of a sub-group of eosinophils called resident eosinophils which are present in the lungs of healthy individuals and which, unlike inflammatory eosinophils, play a regulatory and protective role while maintaining the balance of the immune system and preventing it from responding in an abnormal way such as observed during an asthma attack. More...
The discovery of these specific eosinophils offers promising therapeutic and prophylactic opportunities for the treatment and prevention of asthma.

The team discovered this sub-type of eosinophil in mice and subsequently in humans. In mice, the nucleus of these resident eosinophils appears as a ring shape or doughnut shape, which makes them easily distinguishable from the other inflammatory eosinophils. In humans, all eosinophils have the same morphology, which could explain why the sub-types have only just been discovered. The scientists have also demonstrated, in both mice and humans, that the resident eosinophils carry an identical marker on their surface, the protein L-selectin or CD62L, which means that they are easily distinguishable from inflammatory eosinophils. Cell phenotyping and cell sorting were performed on a FACSAria III (BD Biosciences, San Jose, CA, USA).

Fabrice Bureau, DVM, PhD, a professor and senior author of the study said, “In the future, the question is to know how to facilitate the production of resident eosinophils, rather than inflammatory eosinophils, in the bone marrow. Indeed, by acting at the top of the cascade, we will have new weapons for the prevention of inflammatory diseases such as allergies or autoimmune diseases.” The study was published on August 22, 2016, in The Journal of Clinical Investigation.

Related Links:
University of Liege
BD Biosciences

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.